We thank Roberts and colleagues for a wonderful March JADA study titled "Antibiotic and Opioid Prescribing for Dental-Related Conditions in Emergency Departments: United States, 2012 Through 2014 (Roberts RM, Bohm MK, Bartoces MG, Fleming-Dutra KE, Hicks LA, Chalmers NI. *JADA.* 2020;151\[3\]:174-181.e1) using IBM MarketScan Research Databases in Treatment Pathways data that draw attention to opioid prescribing in hospital emergency departments (EDs) for dental problems. We have published in JADA about ED visits for dental problems and found that over 1.4 million occur each year in the United States.[@bib1] Inserting this context into the Roberts and colleagues' study finding that about 40% of dental-related ED visits result in an opioid prescription and about 55% result in an antibiotic prescription help quantify the issue.

Problematically, physicians have limited knowledge of oral health and prescribe opioids and antibiotics to postpone the need for dental intervention. Importantly, as we write this letter to the editor, dentists around the country are being advised to stop elective care in response to the COVID-19 crisis. Many dental offices are choosing to practice aerosol-free dentistry, which essentially means postponing dental services.

During this crisis, we must pay heed to Roberts and colleagues' study, which shows that, when direct emergency dental care is inaccessible, clinicians frequently resort to antibiotics and opioids. Prescribing both have consequences, but opioids have been identified as a gateway drug for heroin[@bib2] and fentanyl[@bib3] and are associated with persistent use and abuse.[@bib4] 2018 was the first in several years that opioid-related mortality actually fell in the United States.[@bib5] ^,^ [@bib6] Dentists and physicians must be very cautious to prevent a trend reversal and consequent worsening of the opioid crisis in 2020 and beyond.
